# Valink Therapeutics (Valink Therapeutics Ltd)

Private limited company registered in London, classed under “Research and experimental development on biotechnology”.

- Company number: 13077801
- Status: Active
- Type: Private limited company
- Incorporated: 11 December 2020
- Registered office: Imperial Translation & Innovation Hub, 84 Wood Lane, London, W12 0BZ.
- Location: London
- Activity: Research and experimental development on biotechnology

## Latest filed profit

No profit figure in its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Valink Therapeutics do?

Private limited company registered in London, classed under “Research and experimental development on biotechnology”.

### How much turnover does Valink Therapeutics make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/valink-therapeutics-13077801

### Is Valink Therapeutics profitable?

Valink Therapeutics's profit isn't public: small companies may file without a profit and loss account.

### How many people work at Valink Therapeutics?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/valink-therapeutics-13077801

### Who runs and owns Valink Therapeutics?

Its directors are Irsyad Noor Abadi Bin Khairil Anuar. Its owners are shown to subscribers.

### Where is Valink Therapeutics based?

Its registered office is Imperial Translation & Innovation Hub, 84 Wood Lane, London, W12 0BZ., in London.

### When was Valink Therapeutics founded?

Valink Therapeutics Ltd was incorporated on 11 December 2020.

### Is Valink Therapeutics still trading?

The register lists Valink Therapeutics Ltd as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-04-13: Total exemption full accounts made up to 31 December 2025
- 2025-08-29: Statement of capital following an allotment of shares on 5 August 2025 · GBP 103,772.57 (and 4 more like it since 28 January 2022)
- 2025-06-19: Total exemption full accounts made up to 31 December 2024
- 2025-05-16: Termination of appointment of Arne Hagen August Scheu as a director on 16 May 2025
- 2024-12-13: Director's details changed for Mr Arne Hagen August Scheu on 10 December 2024
- 2024-12-13: Director's details changed for Mr Irsyad Noor Abadi Bin Khairil Anuar on 10 December 2024
- 2024-09-02: Total exemption full accounts made up to 31 December 2023
- 2023-11-03: Registered office address changed from Unit 306 Westbourne Studios 242 Acklam Road London W10 5JJ United Kingdom to Imperial Translation & Innovation Hub 84 Wood Lane London W12…
- 2023-11-03: Certificate of change of name
- 2023-09-18: Total exemption full accounts made up to 31 December 2022
- 2023-09-05: Notification of a person with significant control statement
- 2023-09-05: Cessation of Arne Hagen August Scheu as a person with significant control on 4 August 2023
- 2023-06-24: Director's details changed for Mr Arne Hagen August Scheu on 23 June 2023
- 2023-06-24: Change of details for Mr Arne Hagen August Scheu as a person with significant control on 23 June 2023
- 2023-05-15: Second filing of a statement of capital following an allotment of shares on 31 December 2022 · GBP 15,925.31
- 2022-09-05: Total exemption full accounts made up to 31 December 2021
- 2022-04-28: Registered office address changed from 36 Butleigh House Healum Avenue Southall Middlesex UB2 4WL United Kingdom to Unit 306 Westbourne Studios 242 Acklam Road London W10 5JJ on…
- 2021-12-22: Director's details changed for Irsyad Noor Abadi Bin Khairil Anuar on 1 December 2021
- 2021-12-22: Change of details for Arne Hagen August Scheu as a person with significant control on 1 December 2021
- 2021-12-22: Director's details changed for Arne Hagen August Scheu on 1 December 2021
- 2021-02-22: Notification of Arne Hagen August Scheu as a person with significant control on 18 February 2021
- 2021-02-22: Withdrawal of a person with significant control statement on 22 February 2021
- 2021-02-18: Termination of appointment of Sheryl Ying Ting Lim as a director on 18 February 2021
- 2020-12-11: Incorporation

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/valink-therapeutics-13077801